http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#Head http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#assertion http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#provenance http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#pubinfo http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#assertion http://purl.obolibrary.org/obo/DOID_1724 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1724 http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00863 http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association http://www.w3.org/2000/01/rdf-schema#label ranitidine tablets are indicated in 1 short term treatment of active duodenal ulcer most patients heal within 4 weeks studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks 2 maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers no placebo controlled comparative studies have been carried out for periods of longer than 1 year 3 the treatment of pathological hypersecretory conditions e g zollinger ellison syndrome and systemic mastocytosis 4 short term treatment of active benign gastric ulcer most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated studies available to date have not assessed the safety of ranitidine in uncomplicated benign gastric ulcer for periods of more than 6 weeks 5 maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers placebo controlled studies have been carried out for 1 year 6 treatment of gerd symptomatic relief commonly occurs within 24 hours after starting therapy with ranitidine tablets 15 mg twice daily 7 treatment of endoscopically diagnosed erosive esophagitis symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with ranitidine tablets 15 mg 4 times daily 8 maintenance of healing of erosive esophagitis placebo controlled trials have been carried out for 48 weeks concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer active benign gastric ulcer hypersecretory states gerd and erosive esophagitis http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00863 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#provenance http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#pubinfo http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#sig http://purl.org/nanopub/x/hasSignature JIbacBh5aGy/ZLY25kOfBM6sQqNFveR9Yn6fFGRqAdeGcZkXvk+4hRAH17LGMqYXpKsJ1N6kDwQ7YJqkombYAbl67XpT3kTU64rB8QFUcNZEB9cxZ99IfFJsRh/yPa5SEoAWWHbzY7AN+y99eRpXOu08QFvorXs2yYrwND+wNdY= http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://purl.org/dc/terms/created 2021-06-13T12:57:54.843+02:00 http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAQzSOAfP8MjuMg6Xf5qZ4a5hURMRHT6nT0cos9kMpSMs https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs